Inventor
SAVITZ ADAM
US12 patents
⚠️ This page may combine multiple inventors who share the name “SAVITZ ADAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICALS INC
8 patentsUS11998525B2Jun 4, 2024
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC5 citations83
US11266627B1Mar 8, 2022
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC12 citations83
US12161622B2Dec 10, 2024
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC2 citations71
US12150929B2Nov 26, 2024
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC2 citations71
US12419859B2Sep 23, 2025
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC0 citations60
US12171743B2Dec 24, 2024
Forms of aticaprant
JANSSEN PHARMACEUTICALS INC0 citations60
US11998524B2Jun 4, 2024
Forms of aticaprant
JANSSEN PHARMACEUTICALS INC0 citations60
US12201610B2Jan 21, 2025
Compositions comprising aticaprant
JANSSEN PHARMACEUTICALS INC0 citations53
ALTO NEUROSCIENCE INC
3 patentsUS12233059B2Feb 25, 2025
Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent
ALTO NEUROSCIENCE INC0 citations59
US12208096B2Jan 28, 2025
Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent
ALTO NEUROSCIENCE INC0 citations59
US12226375B1Feb 18, 2025
Method of treatment and selection of patients benefiting from agomelatine based on EEG measurements
ALTO NEUROSCIENCE INC0 citations53